|
J Biol Chem, Vol. 274, Issue 16, 11038-11045, April 16, 1999
Sphingolipid Activator Proteins Are Required for Epidermal
Permeability Barrier Formation
Thomas
Doering ,
Walter M.
Holleran§,
Astrid
Potratz ,
Gabriele
Vielhaber ,
Peter M.
Elias§,
Kunihiko
Suzuki , and
Konrad
Sandhoff
From the Kekulé-Institut für Organische
Chemie und Biochemie, Universität Bonn, Gerhard-Domagk-Strasse 1, D-53121 Bonn, Germany, the § Department of Dermatology,
School of Medicine, University of California and the Dermatology
Service and Research Unit (190), Veterans Affairs Medical Center, San
Francisco, California 94121, and the Departments of Neurology
and Psychiatry, School of Medicine, University of North Carolina,
Chapel Hill, North Carolina, 27599
The epidermal permeability barrier is maintained
by extracellular lipid membranes within the interstices of the stratum
corneum. Ceramides, the major components of these multilayered
membranes, derive in large part from hydrolysis of glucosylceramides
mediated by stratum corneum -glucocerebrosidase ( -GlcCerase).
Prosaposin (pSAP) is a large precursor protein that is proteolytically
cleaved to form four distinct sphingolipid activator proteins, which
stimulate enzymatic hydrolysis of sphingolipids, including
glucosylceramide. Recently, pSAP has been eliminated in a mouse model
using targeted deletion and homologous recombination. In addition to
the extracutaneous findings noted previously, our present data indicate
that pSAP deficiency in the epidermis has significant consequences
including: 1) an accumulation of epidermal glucosylceramides together
with below normal levels of ceramides; 2) alterations in lipids that are bound by ester linkages to proteins of the cornified cell envelope;
3) a thickened stratum lucidum with evidence of scaling; and 4) a
striking abnormality in lamellar membrane maturation within the
interstices of the stratum corneum. Together, these results demonstrate
that the production of pSAP, and presumably mature sphingolipid
activator protein generation, is required for normal epidermal barrier
formation and function. Moreover, detection of significant amounts of
covalently bound -OH-GlcCer in pSAP-deficient epidermis suggests
that deglucosylation to -OH-Cer is not a requisite step prior to
covalent attachment of lipid to cornified envelope proteins.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Matzner, B. Breiden, G. Schwarzmann, A. Yaghootfam, A. L. Fluharty, A. Hasilik, K. Sandhoff, and V. Gieselmann
Saposin B-dependent Reconstitution of Arylsulfatase A Activity in Vitro and in Cell Culture Models of Metachromatic Leukodystrophy
J. Biol. Chem.,
April 3, 2009;
284(14):
9372 - 9381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marza, K. T. Simonsen, N. J. Faergeman, and G. M. Lesa
Expression of ceramide glucosyltransferases, which are essential for glycosphingolipid synthesis, is only required in a small subset of C. elegans cells
J. Cell Sci.,
March 15, 2009;
122(6):
822 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zuo, D. Z. Zhuang, R. Han, G. Isaac, J. J. Tobin, M. McKee, R. Welti, J. L. Brissette, M. L. Fitzgerald, and M. W. Freeman
ABCA12 Maintains the Epidermal Lipid Permeability Barrier by Facilitating Formation of Ceramide Linoleic Esters
J. Biol. Chem.,
December 26, 2008;
283(52):
36624 - 36635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-P. Charles, M. Guitard, C. Leyvraz, B. Breiden, M. Haftek, Z. Haftek-Terreau, J.-C. Stehle, K. Sandhoff, and E. Hummler
Postnatal Requirement of the Epithelial Sodium Channel for Maintenance of Epidermal Barrier Function
J. Biol. Chem.,
February 1, 2008;
283(5):
2622 - 2630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Epp, G. Furstenberger, K. Muller, S. de Juanes, M. Leitges, I. Hausser, F. Thieme, G. Liebisch, G. Schmitz, and P. Krieg
12R-lipoxygenase deficiency disrupts epidermal barrier function
J. Cell Biol.,
April 9, 2007;
177(1):
173 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vasireddy, Y. Uchida, N. Salem Jr, S. Y. Kim, M. N. A. Mandal, G. B. Reddy, R. Bodepudi, N. L. Alderson, J. C. Brown, H. Hama, et al.
Loss of functional ELOVL4 depletes very long-chain fatty acids (>=C28) and the unique {omega}-O-acylceramides in skin leading to neonatal death
Hum. Mol. Genet.,
March 1, 2007;
16(5):
471 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jennemann, R. Sandhoff, L. Langbein, S. Kaden, U. Rothermel, H. Gallala, K. Sandhoff, H. Wiegandt, and H.-J. Grone
Integrity and Barrier Function of the Epidermis Critically Depend on Glucosylceramide Synthesis
J. Biol. Chem.,
February 2, 2007;
282(5):
3083 - 3094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miyazaki, A. Dobrzyn, P. M. Elias, and J. M. Ntambi
Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development
PNAS,
August 30, 2005;
102(35):
12501 - 12506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leyvraz, R.-P. Charles, I. Rubera, M. Guitard, S. Rotman, B. Breiden, K. Sandhoff, and E. Hummler
The epidermal barrier function is dependent on the serine protease CAP1/Prss8
J. Cell Biol.,
August 1, 2005;
170(3):
487 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aho, K. Li, Y. Ryoo, C. McGee, A. Ishida-Yamamoto, J. Uitto, and J. F. Klement
Periplakin Gene Targeting Reveals a Constituent of the Cornified Cell Envelope Dispensable for Normal Mouse Development
Mol. Cell. Biol.,
July 15, 2004;
24(14):
6410 - 6418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Herrmann, F. van der Hoeven, H.-J. Grone, A. F. Stewart, L. Langbein, I. Kaiser, G. Liebisch, I. Gosch, F. Buchkremer, W. Drobnik, et al.
Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy
J. Cell Biol.,
June 23, 2003;
161(6):
1105 - 1115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Doering, H. Brade, and K. Sandhoff
Sphingolipid metabolism during epidermal barrier development in mice
J. Lipid Res.,
October 1, 2002;
43(10):
1727 - 1733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vielhaber, L. Brade, B. Lindner, S. Pfeiffer, R. Wepf, U. Hintze, K.-P. Wittern, and H. Brade
Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide
Glycobiology,
June 1, 2001;
11(6):
451 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Schuette, B. Pierstorff, S. Huettler, and K. Sandhoff
Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis
Glycobiology,
June 1, 2001;
11(6):
81R - 90R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Uchida, M. Hara, H. Nishio, E. Sidransky, S. Inoue, F. Otsuka, A. Suzuki, P. M. Elias, W. M. Holleran, and S. Hamanaka
Epidermal sphingomyelins are precursors for selected stratum corneum ceramides
J. Lipid Res.,
December 1, 2000;
41(12):
2071 - 2082.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Wendeler, T. Kolter, and K. Sandhoff
Pathology of Glycosphingolipid Metabolism: The Molecular and Cellular Basis of Neurodegenerative Disease
Neuroscientist,
August 1, 2000;
6(4):
285 - 296.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Brade, G. Vielhaber, E. Heinz, and H. Brade
In vitro characterization of anti-glucosylceramide rabbit antisera
Glycobiology,
June 1, 2000;
10(6):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Nemes, L. N. Marekov, L. Fesus, and P. M. Steinert
A novel function for transglutaminase 1: Attachment of long-chain omega -hydroxyceramides to involucrin by ester bond formation
PNAS,
July 20, 1999;
96(15):
8402 - 8407.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|